☰

Arup Bhattacharya, Ph.D.

Affiliations: 
2005 State University of New York, Buffalo, Buffalo, NY, United States 
Area:
Medical Biophysics, Oncology
Google:
"Arup Bhattacharya"
Mean distance: (not calculated yet)
 
Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor
Richard Mazurchuk grad student 2005 SUNY Buffalo
 (Non-invasive in vivo assessment of tumor hypoxia using functional magnetic resonance (fMR) imaging during therapy in human head and neck squamous cell carcinoma (HNSCC) xenografts: Implications for assessing therapeutic efficacy.)

Children

Sign in to add trainee

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Yang L, Li Y, Bhattacharya A, et al. (2019) A recombinant human protein targeting HER2 overcomes drug resistance in HER2-positive breast cancer. Science Translational Medicine. 11
Rustum YM, Chintala S, Durrani FA, et al. (2018) Non-Coding Micro RNAs and Hypoxia-Inducible Factors Are Selenium Targets for Development of a Mechanism-Based Combination Strategy in Clear-Cell Renal Cell Carcinoma-Bench-to-Bedside Therapy. International Journal of Molecular Sciences. 19
Zakharia Y, Bhattacharya A, Rustum YM. (2018) Selenium targets resistance biomarkers enhancing efficacy while reducing toxicity of anti-cancer drugs: preclinical and clinical development. Oncotarget. 9: 10765-10783
Yang L, Li Y, Bhattacharya A, et al. (2018) Abstract 552: PEPD is an essential regulator of p53 tumor suppressor Cancer Research. 78: 552-552
Yang L, Li Y, Bhattacharya A, et al. (2016) Dual inhibition of ErbB1 and ErbB2 in cancer by recombinant human prolidase mutant hPEPD-G278D. Oncotarget
Veeranki OL, Bhattacharya A, Tang L, et al. (2015) Cruciferous vegetables, isothiocyanates, and prevention of bladder cancer. Current Pharmacology Reports. 1: 272-282
Yang L, Li Y, Bhattacharya A, et al. (2015) Inhibition of ERBB2-overexpressing Tumors by Recombinant Human Prolidase and Its Enzymatically Inactive Mutant. Ebiomedicine. 2: 396-405
Yang L, Li Y, Bhattacharya A, et al. (2015) Abstract P6-07-04: Targeting ErbB2 with human PEPD Cancer Research. 75
Bhattacharya A, Li Y, Shi Y, et al. (2013) Enhanced inhibition of urinary bladder cancer growth and muscle invasion by allyl isothiocyanate and celecoxib in combination. Carcinogenesis. 34: 2593-9
Bhattacharya A, Li Y, Geng F, et al. (2012) The principal urinary metabolite of allyl isothiocyanate, N-acetyl-S-(N-allylthiocarbamoyl)cysteine, inhibits the growth and muscle invasion of bladder cancer. Carcinogenesis. 33: 394-8
See more...